The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 32, No. 12, pp. 1310-1316. DOI 10.1345/aph.18057
© 1998 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, J.
Right arrow Articles by Rivera, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, J.
Right arrow Articles by Rivera, N.

Research Articles

Infection and atherosclerosis--focus on cytomegalovirus and Chlamydia pneumoniae

JW Cheng and NG Rivera

BACKGROUND AND OBJECTIVE: Numerous studies have reported an association of coronary atherosclerosis and restenosis with certain bacterial and viral infections. This article reviews the pathophysiology of atherosclerosis, the role of infectious agents (i.e, cytomegalovirus and Chlamydia pneumoniae) in atherogenesis, and studies supporting the potential beneficial effects of antibiotics or antiviral agents in the management of atherosclerotic disease. DATA SOURCES: English-language clinical studies, abstracts, and review articles pertaining to infectious agents and coronary atherosclerosis. STUDY SELECTION AND DATA EXTRACTION: Relevant seroepidemiologic and pathologic studies and animal models evaluating the role of cytomegalovirus or C. pneumoniae in coronary atherosclerosis. DATA SYNTHESIS: Studies evaluating the possible role of cytomegalovirus and C. pneumoniae in the pathogenesis of atherosclerosis, as well as studies examining the use of antimicrobial and antiviral agents for reduction of cardiovascular events, are reviewed and critiqued. CONCLUSIONS: Current data do not allow us to determine whether infection is a cause or a cofactor of atherosclerosis. These uncertainties can be resolved by larger scale seroepidemiologic, pathologic, and interventional studies. Such efforts will contribute to identifying populations that are appropriate for particular surveillance or specific interventions, such as antibiotics or antiviral therapy.


This article has been cited by other articles:


Home page
 ANGIOLOGYHome page
V. Mallika, B. Goswami, and M. Rajappa
Atherosclerosis Pathophysiology and the Role of Novel Risk Factors: A Clinicobiochemical Perspective
Angiology, November 1, 2007; 58(5): 513 - 522.
[Abstract] [PDF]

Home page
 Eur Heart JHome page
G. Rutger Persson, O. Ohlsson, T. Pettersson, and S. Renvert
Chronic periodontitis, a significant relationship with acute myocardial infarction
Eur. Heart J., December 1, 2003; 24(23): 2108 - 2115.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. A. Hegele, C. P. Busch, T. K. Young, P. W. Connelly, and H. Cao
Mannose-binding Lectin Gene Variation and Cardiovascular Disease in Canadian Inuit
Clin. Chem., August 1, 1999; 45(8): 1283 - 1285.
[Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 1998 by Harvey Whitney Books Company.